Sign up to access historical data
Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
$78,000 |
 |
AmarinAMRN |
$410,000 |
 |
Gilead SciencesGILD |
-$1.19B |
 |
Anavex Life SciencesAVXL |
-$6.3M |
 |
AmgenAMGN |
-$98M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| AULT MILTON C III | Oct 3, 2025 | Sell | 65,903 | $2.4413 | $160,000 |
| AULT MILTON C III | Oct 2, 2025 | Sell | 20,686 | $2.394 | $50,000 |
| AULT MILTON C III | Oct 1, 2025 | Sell | 36,777 | $2.3487 | $86,000 |
| AULT MILTON C III | Sep 30, 2025 | Sell | 3,566 | $2.3334 | $8,300 |
| AULT MILTON C III | Sep 29, 2025 | Sell | 38,324 | $2.309 | $88,000 |
| AULT MILTON C III | Sep 26, 2025 | Sell | 37,738 | $2.3145 | $87,000 |
| AULT MILTON C III | Sep 25, 2025 | Sell | 14,628 | $2.3126 | $34,000 |
| AULT MILTON C III | Sep 24, 2025 | Sell | 39,140 | $2.309 | $90,000 |
| AULT MILTON C III | Sep 23, 2025 | Sell | 43,238 | $2.3757 | $100,000 |
| AULT MILTON C III | Sep 19, 2025 | Sell | 77,009 | $2.3485 | $180,000 |
| AULT MILTON C III | Sep 18, 2025 | Sell | 20,870 | $2.4673 | $51,000 |
| AULT MILTON C III | Sep 17, 2025 | Sell | 2,121 | $2.4535 | $5,200 |
| AULT MILTON C III | Jul 31, 2025 | Sell | 100,000 | $2.2155 | $220,000 |
| AULT MILTON C III | Jul 30, 2025 | Sell | 29,449 | $2.5122 | $74,000 |
| AULT MILTON C III | Jul 28, 2025 | Sell | 8,311 | $2.6849 | $22,000 |
| AULT MILTON C III | Jul 25, 2025 | Sell | 36,532 | $2.8976 | $110,000 |
| AULT MILTON C III | Jul 24, 2025 | Sell | 9,621 | $2.9349 | $28,000 |
| AULT MILTON C III | Jul 23, 2025 | Sell | 59,516 | $2.9502 | $180,000 |
| AULT MILTON C III | May 12, 2025 | Sell | 1,213 | $5.0604 | $6,100 |
| AULT MILTON C III | May 12, 2025 | Sell | 11 | $5.2801 | $58 |
| Horne William B. | Mar 26, 2025 | Buy | 3,334 | $0.9854 | $3,300 |
| AULT MILTON C III | Mar 21, 2025 | Buy | 2,905 | $1.022 | $3,000 |
| Katzoff David J | Mar 21, 2025 | Buy | 5,000 | $1.0096 | $5,000 |
| Horne William B. | Mar 20, 2025 | Buy | 5,000 | $0.9783 | $4,900 |
| Horne William B. | Mar 18, 2025 | Buy | 5,000 | $0.9703 | $4,900 |
| AULT MILTON C III | Mar 18, 2025 | Buy | 5,000 | $0.962 | $4,800 |
| AULT MILTON C III | Mar 12, 2025 | Buy | 100 | $0.6842 | $68 |
| AULT MILTON C III | Aug 6, 2024 | Buy | 75 | $2.75 | $210 |
| AULT MILTON C III | Jul 31, 2024 | Buy | 25 | $3.7368 | $93 |
| AULT MILTON C III | Apr 19, 2024 | Buy | 1,000 | $0.6882 | $690 |
| AULT MILTON C III | Apr 1, 2024 | Buy | 334 | $0.9109 | $300 |
| AULT MILTON C III | Mar 26, 2024 | Buy | 780,000 | $0 | $0 |
| AULT MILTON C III | Mar 26, 2024 | Buy | 780 | $1000 | $780,000 |
| AULT MILTON C III | Jan 31, 2024 | Buy | 1,220,000 | $0 | $0 |
| AULT MILTON C III | Jan 31, 2024 | Buy | 1,220 | $1000 | $1.2M |
| AULT MILTON C III | Jan 5, 2024 | Buy | 2,000 | $1.0635 | $2,100 |
| AULT MILTON C III | Jan 5, 2024 | Buy | 5,000 | $1.0185 | $5,100 |
| McGrath Lynne Fahey | Dec 26, 2023 | Sell | 666 | $0.881 | $590 |
| AULT MILTON C III | Dec 26, 2023 | Buy | 500 | $0.9 | $450 |
| AULT MILTON C III | Dec 22, 2023 | Buy | 200 | $0.9242 | $180 |
What's the latest insider transaction for Alzamend Neuro?
The most recent insider transaction for Alzamend Neuro was conducted by AULT MILTON C III, who sold 65,903 shares on October 3, 2025 at a price of $2.44 per share.
Which insider bought the most ALZN stock over the last two years?
AULT MILTON C III has bought the most ALZN stock in the last 2 years, with a total value of $2M.
Which insider has sold the most ALZN stock over the last two years?
AULT MILTON C III has sold the most ALZN stock in the last 2 years, with a total value of $1.6M.
What is the total value of insider transactions for Alzamend Neuro (ALZN) in the last 2 years?
According to our estimates, the total value of insider transactions for Alzamend Neuro in the last 2 years is positive, amounting to $460,000. This indicates that insiders have predominantly bought shares, showcasing their confidence in the company's future prospects.
How do insider transactions over the last 2 years reflect on Alzamend Neuro's market confidence?
Over the last 2 years, insider transactions for Alzamend Neuro have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
